Back to home
MapLight Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing treatments for central nervous system disorders
MPLTNASDAQ
EPS (TTM)
N/A
Dividend
N/A
Market Cap
N/A
P/E Ratio
N/A
Use ← → arrow keys to navigate
Loading Financial Data
Fetching revenue breakdown...